Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Not Applicable

Completed

• Conditions: Edema Due to Obstruction of Lymph Vessels or Excision of Lymph Nodes

• Registration Number: NCT04749342
• Lead Sponsor: Ahmed Mohamed Abdelrauf

Brief Summary

The purpose of this study is to:

Find out the efficacy of using complete decongestive physiotherapy on limb volume in advanced secondary upper and lower extremity lymphedema patients.

Find out the efficacy of compression bandaging on limb volume in advanced lymphedema patients.

This study was conducted to compare between the efficacy of complete decongestive therapy (CDT) and compression bandaging in advanced secondary lower extremity lymphedema.

Detailed Description

The study was conducted at the department of plastic surgery, Kasr Al-Ainy hospital. Sixty patients of both genders aged from 40 to 55 years old were participated in this study, and they were randomly assigned to two study groups.

Group I: Thirty patients received CDT (60 min of manual lymph drainage MLD, compression bandaging, exercises, and skin care).

Group II: Thirty patients received compression bandaging alone. The same bandaging scheme used for both groups. The therapy included 12 interventions performed 5 days a week, during the first two weeks in addition to another successive two sessions at the third week, i.e., for a total of twelve sessions.

Evaluation of limb volume using water volumetry and 4-cm truncated cone circumferential measurements were done before treatment application, after 6 sessions (post 1) and after 12 sessions (post 2).

Study Timeline

• Study Start: 2019-03-01
• Study First Submitted: 2021-02-06
• Study First Submitted QC: 2021-02-06
• Study First Posted: 2021-02-11
• Primary Completion: 2021-03-01
• Study Completion: 2021-05-01
• Status Verified: 2021-07
• Last Update Submitted: 2021-07-14
• Last Update Posted: 2021-07-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with lower limb lymphedema (stage II and III) secondary lymphedema aged from 40 to 55 years old, with BMI less than 35 and duration of illness ranged from 3-9 years were included in the study

Exclusion Criteria

the patients were excluded if they have acute erysipelas, acute thrombophlebitis phlebothrombosis and decompensated heart failure.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
Limb Volume	1 Month	girth Limb Measurement

Trial Locations

Locations (1)

cairo University; 🇪🇬 Cairo, Dokky, Giza, Egypt